Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects
Authors:
- Wolfgang MiesbachWMWolfgang Miesbach
- Inge ScharrerISInge Scharrer
- Agnes HenschenAHAgnes Henschen
- Marguerite Neerman-ArbezMNMarguerite Neerman-Arbez
- Silvia SpitzerSSSilvia Spitzer
- Dennis GalanakisDGDennis Galanakis
- 1 January 2010
- journal article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 21 (1) , 35-40
Abstract
Hereditary dysfibrinogenemia is a rare clotting disorder, which results from mutations in at least one of the three fibrinogen genes. We examined the frequency of hemostatic clinical and laboratory anomalies at presentation of 37 probands from 12 unrelated families with five different defects (Aalpha R16C, gamma A357T, gamma318-319 del, gamma M310T, and Aalpha R16S), among. The median age was 51 years (11-86 years). Among 62% who were women three (13%) had experienced one or more spontaneous abortion. More than half of the probands had experienced one or more undue bleeding episode, easy bruising being by far the most common. In 19% of probands (9/37, all above age of 50 years), had experienced at least one episode of arterial or venous thrombosis. Among these, were two (7%) with deep venous thrombosis, seven with arterial thrombosis, and five (14%) had experienced both. We propose that the higher frequency of prolonged PT than aPTT, in ours and in other reported studies, reflects the polymerization delay, which in aPTT is attenuated owing to contact activation prior to calcium addition.Keywords
This publication has 21 references indexed in Scilit:
- Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancyBlood Coagulation & Fibrinolysis, 2009
- The fibrinogen Aα R16C mutation results in fibrinolytic resistanceBritish Journal of Haematology, 2006
- The dysfibrinogenaemiasBritish Journal of Haematology, 2001
- Inherited Dysfibrinogenemia: Emerging Abnormal Structure Associations With Pathologic and Nonpathologic DysfunctionsSeminars in Thrombosis and Hemostasis, 1993
- Unusual Aα16Arg→Cys dysfibrinogenaemic family:Blood Coagulation & Fibrinolysis, 1993
- Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.Journal of Clinical Investigation, 1989
- FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE*Annals of the New York Academy of Sciences, 1983
- Novel Structure Elucidation Strategy for Genetically Abnormal Fibrinogens with Incomplete Fibrinopeptide Release as Applied to Fibrinogen SchwarzachHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1983
- High-Performance Liquid Chromatography of Proteins as Applied to Fibrinogen ChainsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1982
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957